|
#16
15.04.2012, 02:39
|
|||
|
|||
|
Разница скорее всего случайна, но вовсе не потому, что смертность не была конечной точкой. Спонсоры возможно обанкротились.
А как прогрессивная общественность относится к альпростадилу и простациклину? 
|
|
#17
15.04.2012, 06:48
|
||||
|
||||
|
Тема о нейропатии-прогрессивная общественность просит выразить мысль во врачебных терминах
|
|
#18
28.04.2012, 19:48
|
||||
|
||||
|
The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 04/28/2012 Clinical Article Fraser DA et al. – The findings suggest that high–dose benfotiamine (300 mg/day) supplementation over 24 months has no significant effects upon peripheral nerve function or soluble markers of inflammation in patients with type 1 diabetes. Methods The study randomly assigned 67 patients with type 1 diabetes to receive 24–month benfotiamine (300 mg/day) or placebo supplementation. Peripheral nerve function and levels of soluble inflammatory variables were assessed at baseline and at 24 months. Fifty–nine patients completed the study. Results Marked increases in whole–blood concentrations of thiamine and thiamine diphosphate were found in the benfotiamine group (both P < 0.001 vs. placebo). However, no significant differences in changes in peripheral nerve function or soluble inflammatory biomarkers were observed between the groups. Read this article in Diabetes Care
|
Линейный вид
